InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Patel Sanjiv, Chief Executive Officer. Director active across 2 companies, notably Relay Therapeutics, Inc.. Cumulatively, 3 reports have been logged. The latest transaction was filed on 12 April 2022 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
€106,55728,000 shares@ €3.80560.0046% mcap87.5% of flow
Common Stock
SEC:0001209191-22-024487:0·
€15,164658 shares@ €23.04630.0010% mcap100.0% of flow
Common Stock
SEC:0001209191-22-002465·
€15,164658 shares@ €23.04630.0006% mcap12.5% of flow
Common Stock
SEC:0001209191-22-002465:0·
3 of 3 declarations
About Patel Sanjiv
Sanjiv Patel is the President and CEO at Relay Therapeutics, Inc. In this role, he is responsible for the strategic direction of the company and the implementation of growth initiatives. With extensive experience in the biopharmaceutical sector, Sanjiv focuses on optimizing the company's performance and creating value for shareholders. His leadership is essential for navigating a constantly evolving economic environment.
